FDA Information
Clinafloxacin is still under clinical development and has not yet received approval from the FDA.
According to the comparative analysis, clinafloxacin is one of the most potent agents against S. pneumoniae. However, other studies have shown severe toxicity (i.e. sever phototoxicity and hypoglycaemia).
Please visit the official site of the FDA for further information.
Why is this medication prescribed?
Dosage and using this medicine
What special precautions should I follow?
What should I do if I forget a dose?
What side effects can this medication cause?
What storage conditions are needed for this medicine?
In case of an emergency/overdose